The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 15, 2022
Filed:
Jun. 10, 2020
Applicant:
Innopeutics Corporation, Seoul, KR;
Inventors:
Sang Hun Lee, Seoul, KR;
Jae Jin Song, Seoul, KR;
Yun Seon Yang, Seoul, KR;
Tae Gyun Kim, Seoul, KR;
Assignee:
INNOPEUTICS CORPORATION, Seoul, KR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); C07K 14/705 (2006.01); A61P 25/28 (2006.01); C07K 14/47 (2006.01); C12N 15/86 (2006.01); A61K 9/00 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/70567 (2013.01); A61K 48/005 (2013.01); A61P 25/28 (2018.01); C07K 14/47 (2013.01); C12N 15/86 (2013.01); A61K 9/0019 (2013.01); A61K 9/0085 (2013.01); A61K 38/00 (2013.01);
Abstract
Disclosed herein is an amyloid β accumulation and/or aggregation inhibitor. A technique for inhibiting amyloid β accumulation and/or aggregation by concurrently introducing Nurr1 and Foxa2 genes and introducing the co-expression of the genes is also provided. When used, the composition can be applied to the prevention or treatment of a neurodegenerative disease caused by amyloid β accumulation and/or aggregation, such as Alzheimer's disease.